Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Development of UM-232, a Covalent STING Antagonist.

ACS medicinal chemistry letters·2026
Same author

Author Correction: Rewiring oncogenic signalling to precision ablation of metastatic cancer.

Nature biomedical engineering·2026
Same author

Development of Next-Generation Fluoroacetamidine-Containing Activity-Based Probes for the Selective Labeling of the Protein Arginine Deiminases (PADs).

ACS chemical biology·2026
Same author

Optimized detection of caspase-6 activation in a murine inflammation model to inform neurodegenerative disease therapies.

PloS one·2026
Same author

Rewiring oncogenic signalling to precision ablation of metastatic cancer.

Nature biomedical engineering·2026
Same author

Improving positively tuned voltage indicators for faster kinetics and higher contrast.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jun 12, 2026

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1
06:18

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1

Published on: March 13, 2018

14.8K

A Robust Fluorogenic Substrate for Chikungunya Virus Protease (nsP2) Activity.

Sparsh Makhaik, Wioletta Rut, Shruti Choudhary

    Biorxiv : the Preprint Server for Biology
    |October 1, 2025
    PubMed
    Summary

    Researchers developed a new fluorogenic substrate, acc-CHIK15-dnp, to screen for chikungunya virus protease (CHIKVP) inhibitors. This tool offers a 20-fold improvement in signal-to-noise ratio, aiding drug development for chikungunya virus infections.

    More Related Videos

    Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods
    10:40

    Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods

    Published on: December 21, 2019

    26.4K
    High-throughput Antiviral Assays to Screen for Inhibitors of Zika Virus Replication
    10:16

    High-throughput Antiviral Assays to Screen for Inhibitors of Zika Virus Replication

    Published on: October 30, 2021

    4.2K

    Related Experiment Videos

    Last Updated: Jun 12, 2026

    Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1
    06:18

    Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1

    Published on: March 13, 2018

    14.8K
    Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods
    10:40

    Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods

    Published on: December 21, 2019

    26.4K
    High-throughput Antiviral Assays to Screen for Inhibitors of Zika Virus Replication
    10:16

    High-throughput Antiviral Assays to Screen for Inhibitors of Zika Virus Replication

    Published on: October 30, 2021

    4.2K

    Area of Science:

    • Virology
    • Drug Discovery
    • Biochemistry

    Background:

    • Chikungunya virus (CHIKV) is a mosquito-borne pathogen with pandemic potential, causing symptoms like fever and joint pain.
    • No specific antiviral treatments exist for CHIKV infection, making drug development a priority.
    • The CHIKV protease nsP2 (CHIKVP) is crucial for viral replication and a key target for antiviral drug development.

    Purpose of the Study:

    • To develop an effective tool for screening CHIKVP inhibitors.
    • To address the lack of suitable screening methods that target critical polyprotein cleavage sites.

    Main Methods:

    • A novel fluorogenic substrate, acc-CHIK15-dnp, was designed using a 15-mer peptide from the CHIKV nsP3/4 junction.
    • The substrate incorporates an ACC-Lys(dnp) donor-quencher pair to measure protease activity.
    • The substrate's performance was compared to the previously reported edab8 substrate.

    Main Results:

    • The new acc-CHIK15-dnp substrate demonstrated a 20-fold higher signal-to-noise ratio compared to edab8.
    • acc-CHIK15-dnp was specifically recognized by CHIKVP, not other alphavirus proteases, highlighting the importance of P-side residues.
    • The improved substrate enabled significantly enhanced high-throughput screening (HTS) for CHIKV inhibitors.

    Conclusions:

    • The acc-CHIK15-dnp substrate is a robust and specific tool for CHIKVP activity assessment.
    • This advancement facilitates more effective small molecule screening for CHIKV drug development.
    • The findings suggest P-side residues are critical for CHIKVP cleavage specificity.